Cogent Biosciences (COGT) Research & Development: 2017-2020
Historic Research & Development for Cogent Biosciences (COGT) over the last 4 years, with Dec 2020 value amounting to $6.1 million.
- Cogent Biosciences' Research & Development fell 41.01% to $6.1 million in Q4 2020 from the same period last year, while for Dec 2020 it was $25.7 million, marking a year-over-year decrease of 41.12%. This contributed to the annual value of $25.7 million for FY2020, which is 41.12% down from last year.
- As of Q4 2020, Cogent Biosciences' Research & Development stood at $6.1 million, which was up 22.09% from $5.0 million recorded in Q3 2020.
- Cogent Biosciences' 5-year Research & Development high stood at $12.4 million for Q1 2019, and its period low was $5.0 million during Q3 2020.
- For the 3-year period, Cogent Biosciences' Research & Development averaged around $9.0 million, with its median value being $9.9 million (2018).
- Its Research & Development has fluctuated over the past 5 years, first surged by 52.33% in 2019, then crashed by 51.69% in 2020.
- Quarterly analysis of 4 years shows Cogent Biosciences' Research & Development stood at $7.6 million in 2017, then soared by 42.36% to $10.8 million in 2018, then declined by 3.82% to $10.4 million in 2019, then slumped by 41.01% to $6.1 million in 2020.
- Its last three reported values are $6.1 million in Q4 2020, $5.0 million for Q3 2020, and $5.1 million during Q2 2020.